193 related articles for article (PubMed ID: 22718190)
21. Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation.
Huang J; Zhou S; Niu X; Hu B; Li Q; Zhang F; Zhang X; Cai X; Lou Y; Liu F; Xu C; Wang Y
Stem Cell Res Ther; 2017 Sep; 8(1):196. PubMed ID: 28927462
[TBL] [Abstract][Full Text] [Related]
22. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.
Raina R; Lou L; Berger B; Vogt B; Do AS; Cunningham R; Vasavada P; Herrmann K; Dell K; Simonson M
BMC Nephrol; 2016 Feb; 17():22. PubMed ID: 26923419
[TBL] [Abstract][Full Text] [Related]
23. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
Nakajima A; Lu Y; Kawano H; Horie S; Muto S
Clin Exp Nephrol; 2015 Dec; 19(6):1199-205. PubMed ID: 25715868
[TBL] [Abstract][Full Text] [Related]
24. Urinary biomarkers at early ADPKD disease stage.
Petzold K; Poster D; Krauer F; Spanaus K; Andreisek G; Nguyen-Kim TD; Pavik I; Ho TA; Serra AL; Rotar L
PLoS One; 2015; 10(4):e0123555. PubMed ID: 25875363
[TBL] [Abstract][Full Text] [Related]
25. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
Cai Y; Tang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
[TBL] [Abstract][Full Text] [Related]
26. Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients.
Zittema D; van den Berg E; Meijer E; Boertien WE; Muller Kobold AC; Franssen CF; de Jong PE; Bakker SJ; Navis G; Gansevoort RT
Clin J Am Soc Nephrol; 2014 Sep; 9(9):1553-62. PubMed ID: 24993447
[TBL] [Abstract][Full Text] [Related]
27. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
[TBL] [Abstract][Full Text] [Related]
28. Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial.
El-Damanawi R; Lee M; Harris T; Mader LB; Bond S; Pavey H; Sandford RN; Wilkinson IB; Burrows A; Woznowski P; Ben-Shlomo Y; Karet Frankl FE; Hiemstra TF
BMJ Open; 2018 May; 8(5):e022859. PubMed ID: 29743334
[TBL] [Abstract][Full Text] [Related]
29. Renal response to prostaglandin E1 infusion in polycystic kidney disease versus non-polycystic renal disease.
Uemasu J; Munemura C; Fujihara M; Kawasaki H
Clin Nephrol; 1995 Oct; 44(4):225-30. PubMed ID: 8575121
[TBL] [Abstract][Full Text] [Related]
30. Effect of Vasopressin on the Hypothalamic-Pituitary-Adrenal Axis in ADPKD Patients during V2 Receptor Antagonism.
Heida JE; Minović I; van Faassen M; Kema IP; Boertien WE; Bakker SJL; van Beek AP; Gansevoort RT
Am J Nephrol; 2020; 51(11):861-870. PubMed ID: 33147589
[TBL] [Abstract][Full Text] [Related]
31. Expanding the role of vasopressin antagonism in polycystic kidney diseases: From adults to children?
Janssens P; Weydert C; De Rechter S; Wissing KM; Liebau MC; Mekahli D
Pediatr Nephrol; 2018 Mar; 33(3):395-408. PubMed ID: 28455745
[TBL] [Abstract][Full Text] [Related]
32. Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease.
Seeman T; Dusek J; Vondrichová H; Kyncl M; John U; Misselwitz J; Janda J
Blood Press Monit; 2003 Jun; 8(3):107-10. PubMed ID: 12900587
[TBL] [Abstract][Full Text] [Related]
33. Increased activity of the renal kallikrein-kinin system in autosomal dominant polycystic kidney disease in rats, but not in humans.
Braun C; Kleemann T; Birck R; Hilgenfeldt U; Riester U; Tschöpe C; van der Woude FJ; Rohmeiss P
Int Immunopharmacol; 2002 Dec; 2(13-14):1949-56. PubMed ID: 12489808
[TBL] [Abstract][Full Text] [Related]
34. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
[TBL] [Abstract][Full Text] [Related]
35. Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease.
Leierer J; Perco P; Hofer B; Eder S; Dzien A; Kerschbaum J; Rudnicki M; Mayer G
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206927
[TBL] [Abstract][Full Text] [Related]
36. Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate.
Pavik I; Jaeger P; Kistler AD; Poster D; Krauer F; Cavelti-Weder C; Rentsch KM; Wüthrich RP; Serra AL
Kidney Int; 2011 Jan; 79(2):234-40. PubMed ID: 20944552
[TBL] [Abstract][Full Text] [Related]
37. Clinical and laboratory markers of autosomal dominant polycystic kidney disease (ADPKD) progression: an overview.
Corradi V; Gastaldon F; Virzì GM; Caprara C; Martino F; Ronco C
Minerva Med; 2015 Feb; 106(1):53-64. PubMed ID: 25300895
[TBL] [Abstract][Full Text] [Related]
38. Early renal and vascular changes in ADPKD patients with low-grade albumin excretion and normal renal function.
Azurmendi PJ; Fraga AR; Galan FM; Kotliar C; Arrizurieta EE; Valdez MG; Forcada PJ; Stefan JS; Martin RS
Nephrol Dial Transplant; 2009 Aug; 24(8):2458-63. PubMed ID: 19332866
[TBL] [Abstract][Full Text] [Related]
39. Nocturnal polyuria and nocturnal arginine vasopressin (AVP): a key factor in the pathophysiology of monosymptomatic nocturnal enuresis.
AbdelFatah D; Shaker H; Ismail M; Ezzat M
Neurourol Urodyn; 2009; 28(6):506-9. PubMed ID: 19260089
[TBL] [Abstract][Full Text] [Related]
40. Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease.
Su Z; Wang X; Gao X; Liu Y; Pan C; Hu H; Beyer RP; Shi M; Zhou J; Zhang J; Serra AL; Wüthrich RP; Mei C
J Intern Med; 2014 Nov; 276(5):470-85. PubMed ID: 24494798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
